Advertisement

Topics

PAREXEL, Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan

14:36 EDT 22 Aug 2017 | Drug Discovery Development

The partnership will aim to drive greater efficiencies in support of patient recruitment for clinical trials in oncology and hematology.
Contributed Author: 
PAREXEL

Original Article: PAREXEL, Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan

NEXT ARTICLE

More From BioPortfolio on "PAREXEL, Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...